Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Allograft rejection 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
2 Allograft rejection 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
3 Allograft rejection 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
4 Allograft rejection 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
5 Allograft rejection 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
6 Antigen processing and presentation 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
7 Antigen processing and presentation 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
8 Asthma 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
9 Asthma 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
10 Asthma 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
11 Asthma 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
12 Asthma 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
13 Autoimmune thyroid disease 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
14 Autoimmune thyroid disease 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
15 Autoimmune thyroid disease 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
16 Autoimmune thyroid disease 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
17 Autoimmune thyroid disease 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
18 Cell adhesion molecules 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
19 Cell adhesion molecules 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
20 Cell adhesion molecules 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
21 Cell adhesion molecules 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
22 Cell adhesion molecules 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
23 Cell adhesion molecules 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
24 Cell adhesion molecules 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
25 Cytokine-cytokine receptor interaction 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
26 Cytokine-cytokine receptor interaction 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
27 Cytokine-cytokine receptor interaction 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
28 Cytokine-cytokine receptor interaction 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
29 Cytokine-cytokine receptor interaction 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
30 Cytokine-cytokine receptor interaction 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
31 Cytokine-cytokine receptor interaction 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
32 Epstein-Barr virus infection 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
33 Epstein-Barr virus infection 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
34 Epstein-Barr virus infection 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
35 Hematopoietic cell lineage 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
36 Hematopoietic cell lineage 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
37 Human immunodeficiency virus 1 infection 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
38 Human immunodeficiency virus 1 infection 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
39 Human T-cell leukemia virus 1 infection 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
40 Human T-cell leukemia virus 1 infection 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
41 Human T-cell leukemia virus 1 infection 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
42 Human T-cell leukemia virus 1 infection 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
43 Human T-cell leukemia virus 1 infection 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
44 Intestinal immune network for IgA production 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
45 Intestinal immune network for IgA production 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
46 Intestinal immune network for IgA production 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
47 Intestinal immune network for IgA production 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
48 Intestinal immune network for IgA production 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
49 Lipid and atherosclerosis 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
50 Lipid and atherosclerosis 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
51 Lipid and atherosclerosis 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
52 Lipid and atherosclerosis 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
53 Lipid and atherosclerosis 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
54 Malaria 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
55 Malaria 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
56 Malaria 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
57 Malaria 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
58 Malaria 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
59 NF-kappa B signaling pathway 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
60 NF-kappa B signaling pathway 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
61 NF-kappa B signaling pathway 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
62 NF-kappa B signaling pathway 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
63 NF-kappa B signaling pathway 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
64 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
65 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
66 Primary immunodeficiency 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
67 Primary immunodeficiency 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
68 Primary immunodeficiency 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
69 Primary immunodeficiency 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
70 Primary immunodeficiency 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
71 Primary immunodeficiency 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
72 Primary immunodeficiency 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
73 Systemic lupus erythematosus 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
74 Systemic lupus erythematosus 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
75 Systemic lupus erythematosus 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
76 Systemic lupus erythematosus 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
77 Systemic lupus erythematosus 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
78 T cell receptor signaling pathway 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
79 T cell receptor signaling pathway 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
80 T cell receptor signaling pathway 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
81 T cell receptor signaling pathway 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
82 Th1 and Th2 cell differentiation 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
83 Th1 and Th2 cell differentiation 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
84 Th17 cell differentiation 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
85 Th17 cell differentiation 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
86 Toll-like receptor signaling pathway 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
87 Toll-like receptor signaling pathway 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
88 Toll-like receptor signaling pathway 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
89 Toxoplasmosis 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
90 Toxoplasmosis 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
91 Toxoplasmosis 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
92 Toxoplasmosis 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
93 Toxoplasmosis 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
94 Transcriptional misregulation in cancer 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
95 Transcriptional misregulation in cancer 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
96 Transcriptional misregulation in cancer 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
97 Viral life cycle - HIV-1 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
98 Viral life cycle - HIV-1 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
99 Viral myocarditis 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
100 Viral myocarditis 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
101 Viral myocarditis 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 3件: 46, 53, 97 💬
102 Viral myocarditis 💬
1件: CD40LG 💬 Frexalimab 💬 Frexalimab 2件: 13, 222 💬
103 Viral myocarditis 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
104 Virion - Human immunodeficiency virus 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
105 Virion - Human immunodeficiency virus 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
106 Yersinia infection 💬
1件: CD4 💬 Anti-human thymocyte immunoglobulin, rabbit 💬 Antithymocyte immunoglobulin (rabbit) 13件: 13, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286, 326 💬
107 Yersinia infection 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬